What is the clinical evidence from this study?

Study design: Observational. Population: rheumatic mitral lesions (n=25). Intervention: Mitral valve replacement vs. Preoperative baseline. Primary outcome: Changes in pulmonary functions (FVC, FEV1, peak expiratory flow rates, TLC, DLCO).

What does this research mean for the field?

Mitral valve replacement causes an immediate postoperative decline in pulmonary functions, followed by gradual recovery over 3 months while still remaining below predicted values. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate longitudinal alterations in pulmonary function test parameters before and after mitral valve replacement across different heart failure symptom classes.

January 1, 2007Annals of Thoracic MedicineOpen Access

Early changes in pulmonary functions after mitral valve replacement

Q: What are the key findings of this study?

Mitral valve replacement was associated with an immediate postoperative decline in pulmonary functions, which gradually recovered over 3 months but remained below predicted values.

View Full Paper

Ask AI

Bookmark

Key result

Mitral valve replacement is linked to early pulmonary function decline that persists below predicted values.

n=25

Why the study?

Changes in pulmonary functions before and after mitral valve replacement in patients with rheumatic mitral lesions were not well characterized.

Does mitral valve replacement improve pulmonary functions in patients with rheumatic mitral lesions?

Comparison

Pulmonary functions preoperatively vs postoperatively at 1 week, 1 month, and 3 months

Design

Observational cohort study

Follow-up

3 months

Authors

SLSuvitesh LuthraUniversity of Southampton PSPankaj SaxenaJohn Hunter Hospital RDRajinderSingh Dhaliwal

Discussion

Member takes

Implication

Post-MVR pulmonary recovery remains incomplete at 3 months; leaves open whether longer follow-up or targeted rehab alters outcomes in rheumatic mitral disease.

Key Points

To evaluate longitudinal alterations in pulmonary function test parameters before and after mitral valve replacement across different heart failure symptom classes.
Prospective study of 25 patients with rheumatic mitral lesions undergoing mitral valve replacement, stratified by New York Heart Association (NYHA) functional class.
Pulmonary function tests were performed preoperatively and postoperatively at 1 week, 1 month, and 3 months.
Preoperatively, FVC, FEV1, and peak expiratory flow rates were reduced across all groups, with TLC and DLCO significantly decreased in NYHA Class III and IV.
Pulmonary functions experienced an acute decline at 1 week post-surgery across all groups before exhibiting gradual recovery over 3 months.
Postoperative improvement was statistically significant only for FVC in NYHA Class IV patients (32.3% improvement, P < 0.05), while other functional values remained below predicted levels without significant differences.

Study Design

Type

Observational (n=25)

Structured PICO

Does mitral valve replacement improve pulmonary functions in patients with rheumatic mitral lesions?

Population

25 patients with rheumatic mitral lesions undergoing mitral valve replacement, evaluated preoperatively and followed for 3 months postoperatively.

Exposure

Mitral valve replacement (MVR)

Outcome

Changes in pulmonary functions (FVC, FEV1, peak expiratory flow rates, TLC, DLCO) evaluated preoperatively and postoperatively at 1 week, 1 month and 3 monthssurrogate

Pulmonary functions deteriorate immediately after mitral valve replacement and recover gradually over 3 months, but generally remain below predicted values.

Cite This Study

Luthra et al. (2007) conducted an observational in rheumatic mitral lesions (n=25). Mitral valve replacement vs. Preoperative baseline was evaluated on Changes in pulmonary functions (FVC, FEV1, peak expiratory flow rates, TLC, DLCO). Mitral valve replacement was associated with an immediate postoperative decline in pulmonary functions, which gradually recovered over 3 months but remained below predicted values.

synapsesocial.com/papers/6ab5fa70e5cc1b7921e40bbd https://doi.org/10.4103/1817-1737.33699

View Full Paper

Ask AI

Bookmark

Implication

Post-MVR pulmonary recovery remains incomplete at 3 months; leaves open whether longer follow-up or targeted rehab alters outcomes in rheumatic mitral disease.

Early changes in pulmonary functions after mitral valve replacement

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Cite This Study

Early changes in pulmonary functions after mitral valve replacement

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Cite This Study

Also Consider

Also Consider